Constellation Pharmaceuticals Presentation Highlights Enhanced EZH2 Target Engagement, Leading to Second-Generation EZH2 Inhibitor CPI-0209

June 12, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search